LFCR - LIFECORE BIOMEDICAL, INC. \DE\
IEX Last Trade
7.24
-0.060 -0.829%
Share volume: 6,560
Last Updated: Fri 27 Dec 2024 08:29:33 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$7.30
-0.06
-0.82%
View ratios
| Fiscal Date | 2021-08-29 | 2021-11-28 | 2022-02-27 | 2022-05-29 | 2022-08-28 | 2022-11-27 | 2023-02-26 | 2023-05-28 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
| Report Date | 2021-10-05 | 2022-01-07 | 2022-04-07 | 2022-09-14 | 2022-10-07 | 2023-03-16 | 2023-06-02 | 2024-03-20 | |
| Assets | |||||||||
| Total Assets | 445.619 M | 422.124 M | 325.582 M | 295.160 M | 285.800 M | 279.073 M | 236.153 M | 253.545 M | |
| Current Assets | 142.409 M | 154.521 M | 132.037 M | 123.712 M | 116.598 M | 127.092 M | 88.439 M | 93.875 M | |
| Inventories | 69.415 M | 79.433 M | 73.700 M | 66.845 M | 64.285 M | 77.524 M | 48.696 M | 40.841 M | |
| Other Current Assets | 9.591 M | 8.721 M | 6.924 M | 7.052 M | 7.157 M | 7.049 M | 4.422 M | 4.919 M | |
| Short Term Investments | 9.591 M | 8.721 M | 6.924 M | 7.052 M | 7.157 M | 7.049 M | 4.422 M | 4.919 M | |
| Total Receivables | 61.956 M | 65.276 M | 49.559 M | 48.172 M | 40.934 M | 35.689 M | 32.371 M | 29.024 M | |
| Current Cash | 1.447 M | 1.091 M | 1.854 M | 1.643 M | 4.222 M | 6.830 M | 2.950 M | 19.091 M | |
| Total Non-current Assets | 303.210 M | 267.603 M | 193.545 M | 171.448 M | 169.202 M | 151.981 M | 147.714 M | 159.670 M | |
| Property Plant Equipment | 180.460 M | 179.929 M | 123.209 M | 130.435 M | 129.024 M | 118.852 M | 120.799 M | 134.390 M | |
| Other Assets | 3.442 M | 3.239 M | 3.048 M | 3.002 M | 2.793 M | 2.605 M | 2.710 M | 2.917 M | |
| Intangible Assets | 35.623 M | 35.127 M | 24.576 M | 15.550 M | 15.275 M | 8.692 M | 4.400 M | 4.200 M | |
| Goodwill | 69.386 M | 37.329 M | 33.916 M | 13.881 M | 13.881 M | 13.881 M | 13.881 M | 13.881 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 445.619 M | 422.124 M | 325.582 M | 295.160 M | 285.800 M | 279.073 M | 236.153 M | 253.545 M | |
| Total liabilities | 251.754 M | 265.922 M | 181.510 M | 187.215 M | 188.901 M | 204.906 M | 163.436 M | 218.457 M | |
| Total current liabilities | 103.653 M | 122.264 M | 90.065 M | 79.231 M | 83.099 M | 195.696 M | 37.673 M | 39.289 M | |
| Accounts Payable | 46.355 M | 59.098 M | 20.014 M | 15.802 M | 16.366 M | 27.971 M | 14.762 M | 22.097 M | |
| Other liabilities | 3.105 M | 3.894 M | 544.000 K | 190.000 K | 199.000 K | 201.000 K | 203.000 K | 68.014 M | |
| Current long term debt | 32.000 M | 42.000 M | 39.900 M | 40.599 M | 46.704 M | 146.953 M | 0.000 | 580.000 K | |
| Long term debt | 123.833 M | 124.194 M | 79.598 M | 97.579 M | 95.865 M | 0.000 | 114.964 M | 101.065 M | |
| Other liabilities | 3.105 M | 3.894 M | 544.000 K | 190.000 K | 199.000 K | 201.000 K | 203.000 K | 68.014 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 193.865 M | 156.202 M | 144.072 M | 107.945 M | 96.899 M | 74.167 M | 72.717 M | 35.088 M | |
| Common stock | 29.424 M | 29.471 M | 29.482 M | 29.487 M | 29.577 M | 29.634 M | 30.304 M | 30.317 M | |
| Retained earnings | 29.103 M | -9.338 M | -22.188 M | -58.851 M | -70.915 M | -99.899 M | -140.091 M | -178.536 M |